Derqui Nieves, Blake Isobel M, Gray Elizabeth J, Cooper Laura V, Grassly Nicholas C, Pons-Salort Margarita, Gaythorpe Katy A M
MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, United Kingdom.
PLOS Glob Public Health. 2024 Nov 26;4(11):e0003749. doi: 10.1371/journal.pgph.0003749. eCollection 2024.
Vaccination timeliness is often not considered among standard performance indicators of routine vaccination programmes, such as vaccination coverage, yet quantifying vaccination delay could inform policies to promote in-time vaccination and help design vaccination schedules. Here, we analysed vaccination timeliness for 24 routine childhood immunisations for 54 countries. We extracted individual vaccination status and timing from Demographic and Health Surveys data from 54 countries with surveys from 2010 onwards. Individual data was used to estimate age at vaccination for <5 year-old children. Recommended age of vaccination for each country and vaccine was compared to the age at vaccination to determine vaccination delay. The evolution of vaccination delay over time was described using estimates from different birth cohorts. To identify socio-demographic indicators associated with delayed vaccination, we used multivariable Cox regression models with country as random effect and estimated the Hazard Ratio for vaccination with each vaccine-dose for each week post recommended vaccination age. Vaccine coverage at the recommended age was highest for birth and first doses (e.g. 50.5% BCG, 18.5% DTP-D1) and lowest for later doses (e.g. 5.5% DTP-D3, 16.3% MCV-D1, 8.2% MCV-D2). Median delay was lowest for birth doses, e.g. BCG (1 week (IQR: 0 to 4)), and it increased with later doses in vaccination courses: 1 (0, 4) week for DTP-D1 versus 4 (2, 9) weeks for DTP-D3. Although the median delay for each vaccine-dose remained largely constant over time, the range of delay estimates moderately decreased. Children living in rural areas, their countries' poorer wealth quintiles and whose mothers had no formal education were more likely to received delayed vaccinations. Although we report most children are vaccinated within the recommended age window, we found little reduction on routine immunisation delays over the last decade and that children from deprived socioeconomic backgrounds are more likely to receive delayed vaccinations.
疫苗接种及时性在常规疫苗接种计划的标准绩效指标(如疫苗接种覆盖率)中往往未被考虑,然而量化疫苗接种延迟可为促进及时接种的政策提供依据,并有助于设计疫苗接种时间表。在此,我们分析了54个国家24种常规儿童免疫接种疫苗的接种及时性。我们从54个国家2010年起进行的人口与健康调查数据中提取了个体疫苗接种状态和时间。个体数据用于估计5岁以下儿童的接种年龄。将每个国家和每种疫苗的推荐接种年龄与实际接种年龄进行比较,以确定疫苗接种延迟情况。利用不同出生队列的估计值描述疫苗接种延迟随时间的变化。为了确定与延迟接种相关的社会人口学指标,我们使用了以国家为随机效应的多变量Cox回归模型,并估计了推荐接种年龄后每周接种每种疫苗剂量的风险比。出生剂量和第一剂疫苗在推荐年龄时的接种覆盖率最高(如卡介苗为50.5%,白百破疫苗第一剂为18.5%),后续剂次的接种覆盖率最低(如白百破疫苗第三剂为5.5%,麻疹风疹腮腺炎联合疫苗第一剂为16.3%,麻疹风疹腮腺炎联合疫苗第二剂为8.2%)。出生剂量的中位数延迟最短,如卡介苗为1周(四分位间距:0至4周),随着接种程序中后续剂次的增加而延长:白百破疫苗第一剂为1(0,4)周,而白百破疫苗第三剂为4(2,9)周。尽管每种疫苗剂量的中位数延迟在很大程度上随时间保持不变,但延迟估计范围略有缩小。生活在农村地区、所在国家财富五分位数较低以及母亲未接受过正规教育的儿童更有可能接受延迟接种。虽然我们报告大多数儿童在推荐年龄范围内接种了疫苗,但我们发现过去十年常规免疫接种延迟几乎没有减少,而且社会经济背景较差的儿童更有可能接受延迟接种。